• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

琥珀酰亚胺基戊二酰胺酸诱导 320 HSR 结肠癌细胞凋亡和 G1 期阻滞。

Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells.

机构信息

Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taiwan, ROC.

出版信息

J Biomed Sci. 2010 Sep 17;17(1):76. doi: 10.1186/1423-0127-17-76.

DOI:10.1186/1423-0127-17-76
PMID:20846458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2949718/
Abstract

BACKGROUND

Histone deacetylases and histone acetyl transferases covalently modify histone proteins, consequentially altering chromatin architecture and gene expression.

METHODS

The effects of suberoylanilide hydroxamic acid, a HDAC inhibitor, on 320 HSR colon cells were assessed in 320 HSR colon cancer cells.

RESULTS

Concentration and time-dependent inhibition of 320 HSR cell proliferation was observed. Treatment of 320 HSR cells with 5 μM SAHA for 72 h significantly inhibited their growth by 50% as compared to that of the control. Fluorescence-activated cell sorting analysis demonstrated significant inhibition of cell cycle progression (sub-G1 arrest) and induction of apoptosis upon various SAHA concentrations after 48 h. In addition, the anti-apoptosis proteins, survivin and Bcl-xL, were significantly inhibited by SAHA after 72 h of treatment. Immunocytochemistry analysis revealed that SAHA-resistant cells were positive for cyclin A (85%), ki-67 (100%), p53 (100%), survivin (100%), and p21 (90%) expression. Furthermore, a significant increase cyclin A-, Ki-67-, p53-, survivin-, and p21-positive cells were noted in SAHA-resistant tumor cells.

CONCLUSION

Our results demonstrated for the first time in 320 HSR colon adenocarcinoma cells that SAHA might be considered as an adjuvant therapy for colon adenocarcinoma.

摘要

背景

组蛋白去乙酰化酶和组蛋白乙酰转移酶通过共价修饰组蛋白蛋白,从而改变染色质结构和基因表达。

方法

在 320 HSR 结肠癌细胞中评估了琥珀酰亚胺基羟肟酸(一种 HDAC 抑制剂)对 320 HSR 结肠癌细胞的影响。

结果

观察到浓度和时间依赖性抑制 320 HSR 细胞增殖。与对照组相比,用 5 μM SAHA 处理 320 HSR 细胞 72 h 可使细胞生长抑制 50%。荧光激活细胞分选分析表明,在不同的 SAHA 浓度下,细胞周期进程(亚 G1 期阻滞)和诱导凋亡在 48 h 后显著抑制。此外,在经过 72 h 的处理后,抗凋亡蛋白 survivin 和 Bcl-xL 也被 SAHA 显著抑制。免疫细胞化学分析显示,SAHA 耐药细胞对细胞周期蛋白 A(85%)、Ki-67(100%)、p53(100%)、survivin(100%)和 p21(90%)的表达呈阳性。此外,在 SAHA 耐药肿瘤细胞中,细胞周期蛋白 A、Ki-67、p53、survivin 和 p21 阳性细胞的数量显著增加。

结论

我们的研究结果首次在 320 HSR 结肠腺癌细胞中表明,SAHA 可能被认为是结肠癌的辅助治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/60deeed96de0/1423-0127-17-76-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/337503dda919/1423-0127-17-76-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/e7d293e4ac4f/1423-0127-17-76-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/7d7caa0b31df/1423-0127-17-76-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/3368982860dd/1423-0127-17-76-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/4a1073dbdf09/1423-0127-17-76-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/f4a8bde4296b/1423-0127-17-76-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/ef5aaacf9190/1423-0127-17-76-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/491aacddca4c/1423-0127-17-76-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/60deeed96de0/1423-0127-17-76-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/337503dda919/1423-0127-17-76-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/e7d293e4ac4f/1423-0127-17-76-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/7d7caa0b31df/1423-0127-17-76-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/3368982860dd/1423-0127-17-76-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/4a1073dbdf09/1423-0127-17-76-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/f4a8bde4296b/1423-0127-17-76-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/ef5aaacf9190/1423-0127-17-76-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/491aacddca4c/1423-0127-17-76-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/2949718/60deeed96de0/1423-0127-17-76-9.jpg

相似文献

1
Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells.琥珀酰亚胺基戊二酰胺酸诱导 320 HSR 结肠癌细胞凋亡和 G1 期阻滞。
J Biomed Sci. 2010 Sep 17;17(1):76. doi: 10.1186/1423-0127-17-76.
2
The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.丁酰苯类异羟肟酸(SAHA)对卵巢癌细胞侵袭表型的抗肿瘤作用及其分子机制。
PLoS One. 2013 Nov 13;8(11):e79781. doi: 10.1371/journal.pone.0079781. eCollection 2013.
3
Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.辛二酰苯胺异羟肟酸通过上调肺癌细胞中肿瘤坏死因子受体1增强肿瘤坏死因子-α的抗癌作用。
Oncotarget. 2017 Mar 14;8(11):17726-17737. doi: 10.18632/oncotarget.14628.
4
SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.SAHA 通过降低组蛋白去乙酰化酶和细胞周期蛋白 D1 和存活素的表达来抑制结肠肿瘤的生长。
Pathol Oncol Res. 2012 Jul;18(3):713-20. doi: 10.1007/s12253-012-9499-7. Epub 2012 Jan 20.
5
Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.组蛋白去乙酰化酶(HDAC)抑制剂,丁酸钠(SAHA),通过 Akt/FOXO3a 信号通路诱导前列腺癌细胞系凋亡。
Med Sci Monit. 2017 Dec 6;23:5793-5802. doi: 10.12659/msm.904597.
6
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer.组蛋白脱乙酰酶抑制剂辛二酰苯胺异羟肟酸可诱导胰腺癌细胞生长抑制,并增强吉西他滨诱导的细胞死亡。
Clin Cancer Res. 2007 Jan 1;13(1):18-26. doi: 10.1158/1078-0432.CCR-06-0914.
7
Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.异羟肟酸苯丁酯在体外和体内对食管鳞状癌细胞的抗癌作用
Dis Esophagus. 2014 Sep-Oct;27(7):693-702. doi: 10.1111/dote.12127. Epub 2013 Sep 4.
8
Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.伏立诺他是一种组蛋白去乙酰化酶(HDAC)抑制剂,可促进细胞周期停滞,并使利妥昔单抗和化疗耐药的淋巴瘤细胞对化疗药物重新敏感。
J Cancer Res Clin Oncol. 2016 Feb;142(2):379-87. doi: 10.1007/s00432-015-2026-y. Epub 2015 Aug 28.
9
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.辛二酰苯胺异羟肟酸(伏立诺他/泽珂)使原位植入BALB/c裸鼠体内的对肿瘤坏死因子相关凋亡诱导配体(TRAIL)耐药的乳腺癌细胞敏感化。
Mol Cancer Ther. 2009 Jun;8(6):1596-605. doi: 10.1158/1535-7163.MCT-08-1004. Epub 2009 Jun 9.
10
A novel suberoylanilide hydroxamic acid histone deacetylase inhibitor derivative, N25, exhibiting improved antitumor activity in both human U251 and H460 cells.一种新型的辛二酰苯胺异羟肟酸组蛋白去乙酰化酶抑制剂衍生物N25,在人U251细胞和H460细胞中均表现出增强的抗肿瘤活性。
Asian Pac J Cancer Prev. 2014;15(10):4331-8. doi: 10.7314/apjcp.2014.15.10.4331.

引用本文的文献

1
γ-Secretase Inhibitor Potentiates the Activity of Suberoylanilide Hydroxamic Acid by Inhibiting Its Ability to Induce Epithelial to Mesenchymal Transition and Stemness via Notch Pathway Activation in Triple-Negative Breast Cancer Cells.γ-分泌酶抑制剂通过抑制其在三阴性乳腺癌细胞中经由Notch信号通路激活诱导上皮-间质转化和干性的能力,增强了辛二酰苯胺异羟肟酸的活性。
ACS Pharmacol Transl Sci. 2023 Sep 5;6(10):1396-1415. doi: 10.1021/acsptsci.3c00099. eCollection 2023 Oct 13.
2
Functionalized Sulfur-Containing Heterocyclic Analogs Induce Sub-G1 Arrest and Apoptotic Cell Death of Laryngeal Carcinoma In Vitro.功能化含硫杂环类似物诱导喉癌细胞体外亚 G1 期阻滞和凋亡。
Molecules. 2023 Feb 15;28(4):1856. doi: 10.3390/molecules28041856.
3

本文引用的文献

1
Functional outcome following restorative rectal cancer surgery.直肠癌修复性手术后的功能结局。
Acta Chir Iugosl. 2009;56(2):9-16. doi: 10.2298/aci0902009z.
2
Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.SAHA的细胞周期和凋亡效应受HCT116多细胞肿瘤球体中细胞微环境的调控。
Eur J Cancer. 2009 Sep;45(13):2402-11. doi: 10.1016/j.ejca.2009.05.026. Epub 2009 Jun 22.
3
Targeted therapy for advanced colorectal cancer--more is not always better.晚期结直肠癌的靶向治疗——并非越多越好。
The beta subunit of AMP-activated protein kinase is critical for cell cycle progression and parasite development in Toxoplasma gondii.AMP 活化蛋白激酶的β亚基对刚地弓形虫的细胞周期进程和寄生虫发育至关重要。
Cell Mol Life Sci. 2022 Sep 28;79(10):532. doi: 10.1007/s00018-022-04556-z.
4
Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells.组蛋白去乙酰化酶抑制剂SAHA作为喉癌细胞潜在的靶向治疗药物
J Cancer. 2017 Jan 1;8(1):19-28. doi: 10.7150/jca.16655. eCollection 2017.
5
Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.顺铂与两种组蛋白去乙酰化酶抑制剂在MCF7、T47D和MDA-MB-231人乳腺癌细胞系中的相互作用评估——等效线图分析
PLoS One. 2015 Nov 18;10(11):e0143013. doi: 10.1371/journal.pone.0143013. eCollection 2015.
6
Decitabine and SAHA-induced apoptosis is accompanied by survivin downregulation and potentiated by ATRA in p53-deficient cells.地西他滨和SAHA诱导的细胞凋亡伴随着生存素的下调,并且在p53缺陷细胞中被全反式维甲酸增强。
Oxid Med Cell Longev. 2014;2014:165303. doi: 10.1155/2014/165303. Epub 2014 Jul 21.
7
Radiosensitizing activity of a novel Benzoxazine through the promotion of apoptosis and inhibition of DNA repair.一种新型苯并恶嗪通过促进细胞凋亡和抑制DNA修复的放射增敏活性。
Invest New Drugs. 2014 Jun;32(3):424-35. doi: 10.1007/s10637-014-0079-4. Epub 2014 Mar 14.
8
Events associated with apoptotic effect of p-Coumaric acid in HCT-15 colon cancer cells.对 HCT-15 结肠癌细胞凋亡作用相关的 p-香豆酸事件。
World J Gastroenterol. 2013 Nov 21;19(43):7726-34. doi: 10.3748/wjg.v19.i43.7726.
9
Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression.双黄升白颗粒对环磷酰胺致骨髓抑制Lewis 荷瘤小鼠细胞周期 CyclinD-CDK4/6 信号通路上下游信号调节剂的双重调控作用。
Onco Targets Ther. 2013;6:199-209. doi: 10.2147/OTT.S37407. Epub 2013 Mar 22.
10
SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.SAHA 通过降低组蛋白去乙酰化酶和细胞周期蛋白 D1 和存活素的表达来抑制结肠肿瘤的生长。
Pathol Oncol Res. 2012 Jul;18(3):713-20. doi: 10.1007/s12253-012-9499-7. Epub 2012 Jan 20.
N Engl J Med. 2009 Feb 5;360(6):623-5. doi: 10.1056/NEJMe0809343.
4
An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.一种组蛋白去乙酰化酶(HDAC)抑制剂曲古抑菌素A以转录依赖的方式诱导细胞在G2/M期转换时出现延迟、纺锤体检查点滑脱及细胞死亡。
Biochem Biophys Res Commun. 2009 Jan 16;378(3):326-31. doi: 10.1016/j.bbrc.2008.11.057. Epub 2008 Nov 25.
5
Estrogen and antiestrogen-dependent regulation of breast cancer cell proliferation in multicellular spheroids: Influence of cell microenvironment.雌激素和抗雌激素对多细胞球体中乳腺癌细胞增殖的依赖性调节:细胞微环境的影响
Int J Oncol. 2008 May;32(5):1033-9. doi: 10.3892/ijo.32.5.1033.
6
Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.辛二酰苯胺异羟肟酸对甲状腺癌细胞系的体内外抗肿瘤活性
Clin Cancer Res. 2006 Sep 15;12(18):5570-7. doi: 10.1158/1078-0432.CCR-06-0367.
7
The case for survivin as a regulator of microtubule dynamics and cell-death decisions.生存素作为微管动力学和细胞死亡决策调节因子的实例。
Curr Opin Cell Biol. 2006 Dec;18(6):609-15. doi: 10.1016/j.ceb.2006.08.015. Epub 2006 Aug 24.
8
Activation of mitochondrial pathway is crucial for tumor selective induction of apoptosis by LAQ824.线粒体途径的激活对于LAQ824对肿瘤细胞凋亡的选择性诱导至关重要。
Cell Cycle. 2006 Aug;5(15):1662-8. doi: 10.4161/cc.5.15.3099. Epub 2006 Aug 1.
9
Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation.辛二酰苯胺异羟肟酸通过抑制核因子-κB激活来增强细胞凋亡、抑制侵袭并消除破骨细胞生成。
J Biol Chem. 2006 Mar 3;281(9):5612-22. doi: 10.1074/jbc.M507213200. Epub 2005 Dec 23.
10
Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.伏立诺他联合吉西他滨可增强非小细胞肺癌细胞的凋亡。
Surgery. 2005 Aug;138(2):360-7. doi: 10.1016/j.surg.2005.06.016.